Projects

Understanding the economic burden of epilepsy in India to develop financial and social protection mechanisms for people with epilepsy and their families

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2026 - Ongoing

Project Lead

Dr. Susmita Chatterjee, Adjunct Faculty, SJRI, Professor and lead, George Institute of Global Health, New Delhi- Study PI, Dr. GRK Sarma, Professor, Neurology, SJMCH-Study site PI

Authors

Dr. GRK Sarma, Dr. Sonia Shivde, Dr. Madonne Rufina Dishani

Project Status

ongoing

Project Type

ICMR funded